Cobenfy 20 mg/1 (Xanomeline and Trospium Chloride CAPSULE, COATED PELLETS) 20 mg/1

Xanomeline and trospium chloride works by acting as a muscarinic agonist, which means it stimulates muscarinic receptors in the brain. The exact mechanism of how this combination treats schizophrenia is not fully understood, but it is believed to modulate cholinergic neurotransmission, which plays a role in cognitive and emotional processing. Trospium chloride helps to mitigate some of the peripheral side effects caused by xanomeline.

The usual dose of Cobenfy is determined by your healthcare provider based on your individual needs and response to the medication. It is typically taken as a capsule by mouth, one hour before or two hours after a meal, twice a day. Always follow the prescribed dosage and do not stop taking the medication without consulting your doctor.

The safety of Cobenfy during pregnancy or breastfeeding has not been established. It is important to discuss the potential risks and benefits with your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding. Your doctor will help you make an informed decision based on your specific situation.

To order Cobenfy from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets. The team will ask you to confirm your trade or institutional credentials and will reply with pricing, availability, shipping, and the import paperwork.

Cobenfy is a unique combination of xanomeline, a muscarinic agonist, and trospium chloride, a muscarinic antagonist. It is designed to manage symptoms of schizophrenia with a different mechanism of action compared to traditional antipsychotic medications. The choice of medication depends on individual patient needs, response to treatment, and side effect profile.

Cobenfy should be stored at room temperature, away from excess heat and moisture. Keep the medication in its original container, tightly closed, and out of reach of children. Do not open, split, chew, or crush the capsules. Always follow the storage instructions provided on the prescription label.

Cobenfy is administered orally as a capsule. It is usually taken one hour before or two hours after a meal, twice a day. Swallow the capsules whole with a glass of water. Do not open, split, chew, or crush the capsules. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand.

The most serious risks to watch for with Cobenfy include high blood pressure, urinary retention, slow-moving gut, orthostatic hypotension (sudden drop in blood pressure upon standing), and extrapyramidal symptoms (movement disorders). If you experience any of these symptoms, contact your healthcare provider immediately.

Cobenfy should not be used by individuals who are allergic to xanomeline, trospium chloride, or any of the inactive ingredients in the medication. It is also not recommended for individuals with certain medical conditions, such as severe liver disease or urinary retention. Always inform your healthcare provider about your medical history and any other medications you are taking before starting Cobenfy.